IP Library Assignment 043414/0552
Patent Assignment
Reel/Frame 043414/0552

Assignment of Assignor's Interest

Recorded: 2017-08-27 Pages: 6
Assignor
GLAXO GROUP LIMITED
Executed: 2017-03-10
Assignee
BASILEA PHARMACEUTICA INTERNATIONAL LTD.
GRENZACHERSTRASSE 487, BASEL, CH-4068, SWITZERLAND
Covered Properties (8)
Treatment of Cell-Mediated Immune Diseases
Patent: 6,589,989 →
Application: 09/485,943 →
Process for the Production of 9-(Z)-Retinoic Acid
Patent: 7,015,353 →
Application: 10/819,693 →
Publication: US 2004/0235951
Treatment of Cell-Mediated Immune Diseases
Patent: 8,541,469 →
Application: 11/432,965 →
Publication: US 2006/0264504
Formulation for Retinoid-Containing Soft Gelatin Capsules
Patent: 8,697,122 →
Application: 12/640,325 →
Publication: US 2010/0136108
Formulation For Retinoid-Containing Soft Gelatin Capsules
Patent: 9,084,823 →
Application: 13/086,479 →
Publication: US 2011/0212170
Formulation for Retinoid-Containing Soft Gelatin Capsules
Patent: 9,084,824 →
Application: 14/191,785 →
Publication: US 2014/0205661
Formulation for Retinoid-Containing Soft Gelatin Capsules
Patent: 9,399,023 →
Application: 14/734,249 →
Publication: US 2015/0265539
Formulation for Retinoid-Containing Soft Gelatin Capsules
Application: 15/192,191 →
Publication: US 2016/0367488
Related Assignments (19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 13, 2000
From: BOLLAG, WERNER; OTT, FRITZ
To: F.HOFFMANN-LA ROCHE AG, A SWISS COMPANY
Reel/Frame 010906/0709 →
Assignment of Assignor's Interest Jun 13, 2000
From: F.HOFFMANN-LA ROCHE AG
To: HOFFMANN-LA ROCHE INC.
Reel/Frame 010906/0706 →
Assignment of Assignor's Interest Apr 2, 2003
From: HOFFMANN-LA ROCHE INC.
To: BASILEA PHARMACEUTICA AG
Reel/Frame 013910/0158 →
Assignment of Assignor's Interest May 9, 2005
From: F.HOFFMAN-LA ROCHE AG
To: HOFFMAN-LA ROCHE INC.
Reel/Frame 016207/0848 →
Assignment of Assignor's Interest May 9, 2005
From: SOUKUP, MILAN; THOMESSEN, ROLF
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 016208/0216 →
Assignment of Assignor's Interest Aug 16, 2006
From: BOLLAG, WERNER; OTT, FRITZ
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 018127/0022 →
Assignment of Assignor's Interest Aug 16, 2006
From: HOFFMANN-LA ROCHE INC.
To: BASILEA PHARMACEUTICA AG
Reel/Frame 018127/0158 →
Assignment of Assignor's Interest Feb 11, 2010
From: DITZINGER, GUNTER; GABRIEL, BERNHARD; SCHMITT-HOFFMANN, ANNE-HORTENSE; WEVELSIEP, LUTZ
To: BASILEA PHARMACEUTICA AG
Reel/Frame 023926/0778 →
Assignment of Assignor's Interest Nov 12, 2012
From: BASILEA PHARMACEUTICA INTERNATIONAL LTD
To: GLAXO GROUP LIMITED
Reel/Frame 029277/0193 →
Assignment of Assignor's Interest Mar 20, 2013
From: HOFFMANN-LA ROCHE INC.
To: GLAXO GROUP LIMITED
Reel/Frame 030053/0906 →
Assignment of Assignor's Interest Aug 15, 2013
From: GLAXO GROUP LIMITED
To: GLAXO GROUP LIMITED
Reel/Frame 031030/0367 →
Assignment of Assignor's Interest May 23, 2014
From: BASILEA PHARMACEUTICA INTERNATIONAL LTD
To: GLAXO GROUP LIMITED
Reel/Frame 033006/0256 →
Assignment of Assignor's Interest May 23, 2014
From: DITZINGER, GUNTER; GABRIEL, BERNHARD; SCHMITT-HOFFMANN, ANNE-HORTENSE; WEVELSIEP, LUTZ
To: BASILEA PHARMACEUTICA AG
Reel/Frame 032954/0938 →
Assignment of Assignor's Interest Jun 10, 2015
From: DITZINGER, GUNTER; GABRIEL, BERNHARD; SCHMITT-HOFFMANN, ANNE-HORTENSE; WEVELSIEP, LUTZ
To: BASILEA PHARMACEUTICA AG
Reel/Frame 035814/0718 →
Assignment of Assignor's Interest Jun 10, 2015
From: BASILEA PHARMACEUTICA INTERNATIONAL LTD.
To: GLAXO GROUP LIMITED
Reel/Frame 035875/0853 →
Assignment of Assignor's Interest Jun 10, 2015
From: BASILEA PHARMACEUTICA INTERNATIONAL LTD.
To: GLAXO GROUP LIMITED
Reel/Frame 035875/0600 →
Assignment of Assignor's Interest Jun 10, 2015
From: DITZINGER, GUNTER; GABRIEL, BERNHARD; SCHMITT-HOFFMANN, ANNE-HORTENSE; WEVELSIEP, LUTZ
To: BASILEA PHARMACEUTICA AG
Reel/Frame 035814/0414 →
Assignment of Assignor's Interest Nov 13, 2020
From: BASILEA PHARMACEUTICA INTERNATIONAL LTD
To: GALEPHAR PHARMACEUTICAL RESEARCH, INC.
Reel/Frame 054358/0326 →
Corrective Assignment to Correct the U.S. Patent 9,399,023 Is Correctnot U.S. Patent 9,339,023 Previously Recorded on Reel 054358 Frame 0326. Assignor(S) Hereby Confirms the Basilea Pharmaceuticainternational Ltd (Nov. 1, 2020). Nov 16, 2020
From: BASILEA PHARMACEUTICA INTERNATIONAL
To: GALEPHAR PHARMACEUTICAL RESEARCH, INC.
Reel/Frame 054421/0390 →